middle.news
How Will Island Pharmaceuticals’ Galidesivir Acquisition Reshape Its Future?
7:04pm on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
How Will Island Pharmaceuticals’ Galidesivir Acquisition Reshape Its Future?
7:04pm on Wednesday 25th of February, 2026 AEDT
Key Points
Half-year loss widens to $4.81 million, up 213.8%
Strategic acquisition of Galidesivir antiviral program from BioCryst
Progress under FDA Animal Rule pathway with potential accelerated approval
Advancement of ISLA-101 clinical trials targeting dengue fever
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ISLAND PHARMACEUTICALS (ASX:ILA)
OPEN ARTICLE